Suppr超能文献

新型冠状病毒肺炎相关肺炎需氧疗患者的死亡率与血氧饱和度及吸入氧分数之间的关联

The Association between Mortality and the Oxygen Saturation and Fraction of Inhaled Oxygen in Patients Requiring Oxygen Therapy due to COVID-19-Associated Pneumonia.

作者信息

Choi Keum-Ju, Hong Hyo-Lim, Kim Eun Jin

机构信息

Department of Internal Medicine, Daegu Veterans Hospital, Daegu, Korea.

Department of Internal Medicine, Daegu Catholic University School of Medicine, Daegu, Republic of Korea.

出版信息

Tuberc Respir Dis (Seoul). 2021 Apr;84(2):125-133. doi: 10.4046/trd.2020.0126. Epub 2020 Dec 28.

Abstract

BACKGROUND

The coronavirus disease (COVID-19) can manifest in a range of symptoms, including both asymptomatic systems which appear nearly non-existent to the patient, all the way to the development of acute respiratory distress syndrome (ARDS). Specifically, COVID-19-associated pneumonia develops into ARDS due to the rapid progression of hypoxia, and although arterial blood gas analysis can assist in halting this deterioration, the current environment provided by the COVID-19 pandemic, which has led to an overall lack of medical resources or equipment, has made it difficult to administer such tests in a widespread manner. As a result, this study was conducted in order to determine whether the levels of oxygen saturation (SpO2) and the fraction of inhaled oxygen (FiO2) (SF ratio) can also serve as predictors of ARDS and the patient's risk of mortality.

METHODS

This was a retrospective cohort study conducted from February 2020 to Mary 2020, with the study's subjects consisting of COVID-19 pneumonia patients who had reached a state of deterioration that required the use of oxygen therapy. Of the 100 COVID-19 pneumonia cases, we compared 59 pneumonia patients who required oxygen therapy, divided into ARDS and non-ARDS pneumonia patients who required oxygen, and then investigated the different factors which affected their mortality.

RESULTS

At the time of admission, the ratios of SpO2, FiO2, and SF for the ARDS group differed significantly from those of the non-ARDS pneumonia support group who required oxygen (p<0.001). With respect to the predicting of the occurrence of ARDS, the SF ratio on admission and the SF ratio at exacerbation had an area under the curve which measured to be around 85.7% and 88.8% (p<0.001). Multivariate Cox regression analysis identified that the SF ratio at exacerbation (hazard ratio [HR], 0.916; 95% confidence interval [CI], 0.846-0.991; p=0.029) and National Early Warning Score (NEWS) (HR, 1.277; 95% CI, 1.010-1.615; p=0.041) were significant predictors of mortality.

CONCLUSION

The SF ratio on admission and the SF ratio at exacerbation were strong predictors of the occurrence of ARDS, and the SF ratio at exacerbation and NEWS held a significant effect on mortality.

摘要

背景

冠状病毒病(COVID-19)可表现出一系列症状,包括对患者而言几乎不存在的无症状情况,一直到发展为急性呼吸窘迫综合征(ARDS)。具体而言,COVID-19相关肺炎由于缺氧迅速进展而发展为ARDS,尽管动脉血气分析有助于阻止这种恶化,但COVID-19大流行导致总体医疗资源或设备短缺的当前环境,使得难以广泛开展此类检测。因此,开展本研究以确定氧饱和度(SpO2)和吸入氧分数(FiO2)(SF比值)水平是否也可作为ARDS及患者死亡风险的预测指标。

方法

这是一项回顾性队列研究,于2020年2月至2020年5月进行,研究对象为病情恶化至需要氧疗的COVID-19肺炎患者。在100例COVID-19肺炎病例中,我们比较了59例需要氧疗的肺炎患者,分为ARDS组和需要氧疗的非ARDS肺炎患者,然后调查影响其死亡率的不同因素。

结果

入院时,ARDS组的SpO2、FiO2和SF比值与需要氧疗的非ARDS肺炎支持组有显著差异(p<0.001)。关于ARDS发生的预测,入院时的SF比值和病情加重时的SF比值的曲线下面积分别约为85.7%和88.8%(p<0.001)。多因素Cox回归分析确定,病情加重时的SF比值(风险比[HR],0.916;95%置信区间[CI],0.846 - 0.991;p = 0.029)和国家早期预警评分(NEWS)(HR,1.277;95% CI,1.010 - 1.615;p = 0.041)是死亡率的显著预测指标。

结论

入院时的SF比值和病情加重时的SF比值是ARDS发生的有力预测指标,病情加重时的SF比值和NEWS对死亡率有显著影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18d4/8010412/8a2f4eef0c8e/trd-2020-0126f1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验